FANCD2 and ovarian carcinoma: Interestingly overexpression of FANCD2 is also associated with worse prognosis in patients with lymph node positive colorectal cancer [19], BRCA1/2 deficient breast tumors [20], ovarian carcinoma [21] as well as metastatic melanoma [22].